17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of IL13RA2 mRNA CTD PMID:17557909 17beta-estradiol multiple interactions ISO RGD:1347847 6480464 4-(2-aminoethyl)benzenesulfonylfluoride inhibits the reaction [[Estradiol co-treated with Progesterone] results in decreased expression of IL13RA2 mRNA] more ... CTD PMID:20660070 17beta-estradiol decreases expression ISO RGD:1347847 6480464 Estradiol results in decreased expression of IL13RA2 mRNA CTD PMID:25878060 17beta-estradiol increases expression ISO RGD:1347847 6480464 Estradiol results in increased expression of IL13RA2 mRNA CTD PMID:21795739 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of IL13RA2 mRNA CTD PMID:26232522 , PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of IL13RA2 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:732072 6480464 Tetrachlorodibenzodioxin affects the expression of IL13RA2 mRNA CTD PMID:26377647 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1347847 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of IL13RA2 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of IL13RA2 mRNA CTD PMID:28628672 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of IL13RA2 mRNA CTD PMID:31881176 all-trans-retinoic acid increases expression ISO RGD:1347847 6480464 Tretinoin results in increased expression of IL13RA2 mRNA CTD PMID:16012519 all-trans-retinoic acid decreases expression ISO RGD:1347847 6480464 Tretinoin results in decreased expression of IL13RA2 mRNA CTD PMID:23724009 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of IL13RA2 mRNA CTD PMID:16483693 Aroclor 1254 decreases expression ISO RGD:732072 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of IL13RA2 mRNA CTD PMID:23650126 arsane decreases expression ISO RGD:1347847 6480464 Arsenic results in decreased expression of IL13RA2 mRNA CTD PMID:19962721 arsane multiple interactions ISO RGD:1347847 6480464 [Arsenic co-treated with Fluorides] results in decreased expression of IL13RA2 mRNA, [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of IL13RA2 mRNA CTD PMID:19962721 , PMID:32525701 arsenic atom decreases expression ISO RGD:1347847 6480464 Arsenic results in decreased expression of IL13RA2 mRNA CTD PMID:19962721 arsenic atom multiple interactions ISO RGD:1347847 6480464 [Arsenic co-treated with Fluorides] results in decreased expression of IL13RA2 mRNA, [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of IL13RA2 mRNA CTD PMID:19962721 , PMID:32525701 benzalkonium chloride increases expression ISO RGD:732072 6480464 Benzalkonium Compounds results in increased expression of IL13RA2 mRNA CTD PMID:30171875 benzo[a]pyrene increases expression ISO RGD:1347847 6480464 Benzo(a)pyrene results in increased expression of IL13RA2 mRNA CTD PMID:22316170 benzo[a]pyrene affects methylation ISO RGD:1347847 6480464 Benzo(a)pyrene affects the methylation of IL13RA2 promoter CTD PMID:27901495 bis(2-chloroethyl) sulfide increases expression ISO RGD:1347847 6480464 Mustard Gas results in increased expression of IL13RA2 mRNA CTD PMID:25102026 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of IL13RA2 mRNA CTD PMID:25181051 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of IL13RA2 mRNA CTD PMID:34947998 bisphenol A decreases expression ISO RGD:732072 6480464 bisphenol A results in decreased expression of IL13RA2 mRNA CTD PMID:35479511 bisphenol A multiple interactions ISO RGD:1347847 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of IL13RA2 mRNA CTD PMID:28628672 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of IL13RA2 gene CTD PMID:28505145 bromobenzene decreases expression EXP 6480464 bromobenzene results in decreased expression of IL13RA2 mRNA CTD PMID:32479839 cadmium dichloride multiple interactions ISO RGD:1347847 6480464 TNF affects the reaction [Cadmium Chloride results in increased expression of IL13RA2 mRNA] CTD PMID:18560533 cadmium dichloride increases expression ISO RGD:1347847 6480464 Cadmium Chloride results in increased expression of IL13RA2 mRNA CTD PMID:18560533 cadmium sulfate multiple interactions ISO RGD:1347847 6480464 [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in decreased expression of IL13RA2 mRNA CTD PMID:18654764 carbon nanotube decreases expression ISO RGD:732072 6480464 Nanotubes, Carbon analog results in decreased expression of IL13RA2 mRNA CTD PMID:25620056 carbon nanotube increases expression ISO RGD:732072 6480464 Nanotubes, Carbon results in increased expression of IL13RA2 mRNA CTD PMID:25554681 chlordecone increases expression ISO RGD:732072 6480464 Chlordecone results in increased expression of IL13RA2 mRNA CTD PMID:33711761 cobalt dichloride multiple interactions ISO RGD:1347847 6480464 [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in decreased expression of IL13RA2 mRNA CTD PMID:18654764 copper atom multiple interactions ISO RGD:1347847 6480464 [NSC 689534 binds to Copper] which results in increased expression of IL13RA2 mRNA CTD PMID:20971185 copper atom decreases expression EXP 6480464 Copper results in decreased expression of IL13RA2 mRNA CTD PMID:30556269 copper(0) multiple interactions ISO RGD:1347847 6480464 [NSC 689534 binds to Copper] which results in increased expression of IL13RA2 mRNA CTD PMID:20971185 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of IL13RA2 mRNA CTD PMID:30556269 crocidolite asbestos increases expression ISO RGD:1347847 6480464 Asbestos, Crocidolite results in increased expression of IL13RA2 mRNA CTD PMID:25351596 cyclosporin A decreases expression ISO RGD:1347847 6480464 Cyclosporine results in decreased expression of IL13RA2 mRNA CTD PMID:33631201 dexamethasone multiple interactions ISO RGD:1347847 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of IL13RA2 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of IL13RA2 mRNA CTD PMID:28628672 dexamethasone multiple interactions ISO RGD:732072 6480464 Genistein affects the reaction [Dexamethasone results in increased expression of IL13RA2 mRNA] CTD PMID:29624291 dexamethasone increases expression ISO RGD:732072 6480464 Dexamethasone results in increased expression of IL13RA2 mRNA CTD PMID:29624291 dibenzo[a,l]pyrene decreases expression ISO RGD:732072 6480464 dibenzo(a, l)pyrene results in decreased expression of IL13RA2 mRNA CTD PMID:25908611 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of IL13RA2 mRNA CTD PMID:21266533 dimethylarsinic acid multiple interactions ISO RGD:732072 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL13RA2 mRNA CTD PMID:34876320 dioxygen decreases expression ISO RGD:1347847 6480464 Oxygen deficiency results in decreased expression of IL13RA2 mRNA CTD PMID:20660070 endosulfan increases expression ISO RGD:1347847 6480464 Endosulfan results in increased expression of IL13RA2 mRNA CTD PMID:30090376 epoxiconazole increases expression ISO RGD:732072 6480464 epoxiconazole results in increased expression of IL13RA2 mRNA CTD PMID:35436446 fluoranthene multiple interactions ISO RGD:732072 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of IL13RA2 mRNA CTD PMID:28329830 folic acid multiple interactions ISO RGD:1347847 6480464 [Folic Acid affects the susceptibility to Pemetrexed] which affects the expression of IL13RA2 mRNA, [Folic Acid deficiency co-treated with Methotrexate] results in increased expression of IL13RA2 mRNA CTD PMID:22975265 , PMID:24657277 folic acid affects methylation EXP 6480464 Folic Acid affects the methylation of IL13RA2 gene CTD PMID:24629913 furan increases expression EXP 6480464 furan results in increased expression of IL13RA2 mRNA CTD PMID:27387713 genistein multiple interactions ISO RGD:732072 6480464 Genistein affects the reaction [Dexamethasone results in increased expression of IL13RA2 mRNA] CTD PMID:29624291 genistein decreases expression ISO RGD:732072 6480464 Genistein results in decreased expression of IL13RA2 mRNA CTD PMID:29624291 glyphosate decreases expression ISO RGD:1347847 6480464 glyphosate results in decreased expression of IL13RA2 mRNA CTD PMID:31295307 imiquimod increases expression ISO RGD:732072 6480464 Imiquimod results in increased expression of IL13RA2 mRNA CTD PMID:31054998 indometacin multiple interactions ISO RGD:1347847 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of IL13RA2 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of IL13RA2 mRNA CTD PMID:28628672 lead(0) affects expression ISO RGD:1347847 6480464 Lead affects the expression of IL13RA2 mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:1347847 6480464 Lead affects the expression of IL13RA2 mRNA CTD PMID:28903495 lead(II) chloride multiple interactions ISO RGD:1347847 6480464 [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in decreased expression of IL13RA2 mRNA CTD PMID:18654764 lipopolysaccharide multiple interactions ISO RGD:1347847 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of IL13RA2 mRNA CTD PMID:35811015 malathion increases expression ISO RGD:1347847 6480464 Malathion results in increased expression of IL13RA2 mRNA CTD PMID:32069766 methotrexate multiple interactions ISO RGD:1347847 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in increased expression of IL13RA2 mRNA CTD PMID:24657277 methylarsonic acid multiple interactions ISO RGD:732072 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL13RA2 mRNA CTD PMID:34876320 mifepristone increases expression ISO RGD:1347847 6480464 Mifepristone results in increased expression of IL13RA2 mRNA CTD PMID:17584828 mitoxantrone affects response to substance ISO RGD:1347847 6480464 IL13RA2 protein affects the susceptibility to Mitoxantrone CTD PMID:16217747 nickel atom increases expression ISO RGD:1347847 6480464 Nickel results in increased expression of IL13RA2 mRNA CTD PMID:25583101 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of IL13RA2 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:732072 6480464 [Soot co-treated with Ozone] results in increased expression of IL13RA2 mRNA CTD PMID:36303316 paclitaxel affects response to substance ISO RGD:1347847 6480464 IL13RA2 protein affects the susceptibility to Paclitaxel CTD PMID:16217747 paraquat increases expression EXP 6480464 Paraquat results in increased expression of IL13RA2 mRNA CTD PMID:32680482 pemetrexed multiple interactions ISO RGD:1347847 6480464 [Folic Acid affects the susceptibility to Pemetrexed] which affects the expression of IL13RA2 mRNA CTD PMID:22975265 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:732072 6480464 [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of IL13RA2 mRNA CTD PMID:36331819 progesterone multiple interactions ISO RGD:1347847 6480464 4-(2-aminoethyl)benzenesulfonylfluoride inhibits the reaction [[Estradiol co-treated with Progesterone] results in decreased expression of IL13RA2 mRNA] more ... CTD PMID:20660070 progesterone decreases expression ISO RGD:1347847 6480464 Progesterone results in decreased expression of IL13RA2 mRNA CTD PMID:20660070 , PMID:20864642 S-(1,2-dichlorovinyl)-L-cysteine increases expression ISO RGD:1347847 6480464 S-(1, 2-dichlorovinyl)cysteine results in increased expression of IL13RA2 mRNA CTD PMID:35811015 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1347847 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of IL13RA2 mRNA CTD PMID:35811015 SB 203580 decreases expression ISO RGD:1347847 6480464 SB 203580 results in decreased expression of IL13RA2 mRNA CTD PMID:20660070 Senkirkine increases expression EXP 6480464 senkirkine results in increased expression of IL13RA2 mRNA CTD PMID:32419051 silicon dioxide increases expression ISO RGD:1347847 6480464 Silicon Dioxide analog results in increased expression of IL13RA2 mRNA, Silicon Dioxide results in increased expression of IL13RA2 mRNA CTD PMID:23806026 , PMID:25351596 sodium arsenate multiple interactions ISO RGD:1347847 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of IL13RA2 mRNA CTD PMID:32525701 sodium arsenate multiple interactions ISO RGD:732072 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL13RA2 mRNA CTD PMID:34876320 sodium arsenite multiple interactions ISO RGD:732072 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL13RA2 mRNA CTD PMID:34876320 sodium dodecyl sulfate increases expression ISO RGD:1347847 6480464 Sodium Dodecyl Sulfate results in increased expression of IL13RA2 mRNA CTD PMID:31734321 succimer multiple interactions ISO RGD:732072 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of IL13RA2 mRNA CTD PMID:21641980 temozolomide increases expression ISO RGD:1347847 6480464 Temozolomide results in increased expression of IL13RA2 mRNA CTD PMID:31758290 tetrachloromethane multiple interactions ISO RGD:732072 6480464 NT5E gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of IL13RA2 mRNA] CTD PMID:18263696 tetrachloromethane increases expression ISO RGD:732072 6480464 Carbon Tetrachloride results in increased expression of IL13RA2 mRNA CTD PMID:25827057 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of IL13RA2 mRNA CTD PMID:25729387 Tributyltin oxide increases expression ISO RGD:732072 6480464 bis(tri-n-butyltin)oxide results in increased expression of IL13RA2 mRNA CTD PMID:18958704 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of IL13RA2 mRNA CTD PMID:33387578 valproic acid affects expression ISO RGD:732072 6480464 Valproic Acid affects the expression of IL13RA2 mRNA CTD PMID:17963808 valproic acid increases expression ISO RGD:1347847 6480464 Valproic Acid results in increased expression of IL13RA2 mRNA CTD PMID:23179753 more ... valproic acid decreases methylation ISO RGD:1347847 6480464 Valproic Acid results in decreased methylation of IL13RA2 gene CTD PMID:29154799 vincaleukoblastine affects response to substance ISO RGD:1347847 6480464 IL13RA2 protein affects the susceptibility to Vinblastine CTD PMID:16217747 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of IL13RA2 mRNA CTD PMID:30207508 vorinostat increases expression ISO RGD:1347847 6480464 vorinostat results in increased expression of IL13RA2 mRNA CTD PMID:27188386 zoledronic acid increases expression ISO RGD:1347847 6480464 zoledronic acid results in increased expression of IL13RA2 mRNA CTD PMID:24714768